SYYC_HUMAN - dbPTM
SYYC_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SYYC_HUMAN
UniProt AC P54577
Protein Name Tyrosine--tRNA ligase, cytoplasmic
Gene Name YARS
Organism Homo sapiens (Human).
Sequence Length 528
Subcellular Localization Cytoplasm .
Protein Description Catalyzes the attachment of tyrosine to tRNA(Tyr) in a two-step reaction: tyrosine is first activated by ATP to form Tyr-AMP and then transferred to the acceptor end of tRNA(Tyr)..
Protein Sequence MGDAPSPEEKLHLITRNLQEVLGEEKLKEILKERELKIYWGTATTGKPHVAYFVPMSKIADFLKAGCEVTILFADLHAYLDNMKAPWELLELRVSYYENVIKAMLESIGVPLEKLKFIKGTDYQLSKEYTLDVYRLSSVVTQHDSKKAGAEVVKQVEHPLLSGLLYPGLQALDEEYLKVDAQFGGIDQRKIFTFAEKYLPALGYSKRVHLMNPMVPGLTGSKMSSSEEESKIDLLDRKEDVKKKLKKAFCEPGNVENNGVLSFIKHVLFPLKSEFVILRDEKWGGNKTYTAYVDLEKDFAAEVVHPGDLKNSVEVALNKLLDPIREKFNTPALKKLASAAYPDPSKQKPMAKGPAKNSEPEEVIPSRLDIRVGKIITVEKHPDADSLYVEKIDVGEAEPRTVVSGLVQFVPKEELQDRLVVVLCNLKPQKMRGVESQGMLLCASIEGINRQVEPLDPPAGSAPGEHVFVKGYEKGQPDEELKPKKKVFEKLQADFKISEECIAQWKQTNFMTKLGSISCKSLKGGNIS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MGDAPSPE
-------CCCCCCHH
11.2019413330
2Acetylation------MGDAPSPEE
------CCCCCCHHH
39.5219413330
6Phosphorylation--MGDAPSPEEKLHL
--CCCCCCHHHHHHH
46.8221815630
10UbiquitinationDAPSPEEKLHLITRN
CCCCHHHHHHHHHHC
39.27-
102-HydroxyisobutyrylationDAPSPEEKLHLITRN
CCCCHHHHHHHHHHC
39.27-
26UbiquitinationQEVLGEEKLKEILKE
HHHHCHHHHHHHHHH
61.6321906983
26AcetylationQEVLGEEKLKEILKE
HHHHCHHHHHHHHHH
61.6326822725
28UbiquitinationVLGEEKLKEILKERE
HHCHHHHHHHHHHCC
54.50-
32UbiquitinationEKLKEILKERELKIY
HHHHHHHHHCCCEEE
61.46-
39PhosphorylationKERELKIYWGTATTG
HHCCCEEEEECCCCC
9.0126074081
42PhosphorylationELKIYWGTATTGKPH
CCEEEEECCCCCCCE
13.4926074081
44PhosphorylationKIYWGTATTGKPHVA
EEEEECCCCCCCEEE
35.6026074081
45PhosphorylationIYWGTATTGKPHVAY
EEEECCCCCCCEEEE
40.5226074081
47AcetylationWGTATTGKPHVAYFV
EECCCCCCCEEEEEE
29.8326051181
52PhosphorylationTGKPHVAYFVPMSKI
CCCCEEEEEEEHHHH
12.2026074081
57PhosphorylationVAYFVPMSKIADFLK
EEEEEEHHHHHHHHH
18.1626074081
70PhosphorylationLKAGCEVTILFADLH
HHHCCEEEEEEHHHH
6.9427251275
79PhosphorylationLFADLHAYLDNMKAP
EEHHHHHHHHCCCCC
12.1127251275
95PhosphorylationELLELRVSYYENVIK
HHHHHHHHHHHHHHH
18.6328152594
96PhosphorylationLLELRVSYYENVIKA
HHHHHHHHHHHHHHH
16.3728152594
97PhosphorylationLELRVSYYENVIKAM
HHHHHHHHHHHHHHH
8.1028152594
104SulfoxidationYENVIKAMLESIGVP
HHHHHHHHHHHCCCC
3.4721406390
107PhosphorylationVIKAMLESIGVPLEK
HHHHHHHHCCCCHHH
22.2319413330
114UbiquitinationSIGVPLEKLKFIKGT
HCCCCHHHCCCCCCC
65.7421906983
116UbiquitinationGVPLEKLKFIKGTDY
CCCHHHCCCCCCCCC
56.99-
119UbiquitinationLEKLKFIKGTDYQLS
HHHCCCCCCCCCCCC
59.9121906983
1192-HydroxyisobutyrylationLEKLKFIKGTDYQLS
HHHCCCCCCCCCCCC
59.91-
126PhosphorylationKGTDYQLSKEYTLDV
CCCCCCCCEEEEEEE
14.1230576142
127UbiquitinationGTDYQLSKEYTLDVY
CCCCCCCEEEEEEEE
64.4321906983
129PhosphorylationDYQLSKEYTLDVYRL
CCCCCEEEEEEEEEH
19.1521406692
130PhosphorylationYQLSKEYTLDVYRLS
CCCCEEEEEEEEEHH
19.9921406692
134PhosphorylationKEYTLDVYRLSSVVT
EEEEEEEEEHHHHHC
12.9021406692
137PhosphorylationTLDVYRLSSVVTQHD
EEEEEEHHHHHCCCC
16.4621406692
138PhosphorylationLDVYRLSSVVTQHDS
EEEEEHHHHHCCCCH
25.7921406692
141PhosphorylationYRLSSVVTQHDSKKA
EEHHHHHCCCCHHHC
20.3121406692
145PhosphorylationSVVTQHDSKKAGAEV
HHHCCCCHHHCCCHH
33.6521406692
146AcetylationVVTQHDSKKAGAEVV
HHCCCCHHHCCCHHH
53.3423236377
146UbiquitinationVVTQHDSKKAGAEVV
HHCCCCHHHCCCHHH
53.3419608861
1462-HydroxyisobutyrylationVVTQHDSKKAGAEVV
HHCCCCHHHCCCHHH
53.34-
146SuccinylationVVTQHDSKKAGAEVV
HHCCCCHHHCCCHHH
53.3423954790
147UbiquitinationVTQHDSKKAGAEVVK
HCCCCHHHCCCHHHH
56.8821906983
154UbiquitinationKAGAEVVKQVEHPLL
HCCCHHHHHCCCHHH
54.52-
190UbiquitinationFGGIDQRKIFTFAEK
CCCCCHHHHHHHHHH
36.22-
190AcetylationFGGIDQRKIFTFAEK
CCCCCHHHHHHHHHH
36.2226051181
190MalonylationFGGIDQRKIFTFAEK
CCCCCHHHHHHHHHH
36.2226320211
197AcetylationKIFTFAEKYLPALGY
HHHHHHHHHHHHCCC
48.9719608861
197UbiquitinationKIFTFAEKYLPALGY
HHHHHHHHHHHHCCC
48.9721906983
198PhosphorylationIFTFAEKYLPALGYS
HHHHHHHHHHHCCCC
14.9323186163
204PhosphorylationKYLPALGYSKRVHLM
HHHHHCCCCCCEECC
16.3323312004
205PhosphorylationYLPALGYSKRVHLMN
HHHHCCCCCCEECCC
16.5223917254
206AcetylationLPALGYSKRVHLMNP
HHHCCCCCCEECCCC
50.3719608861
206UbiquitinationLPALGYSKRVHLMNP
HHHCCCCCCEECCCC
50.3721890473
206MalonylationLPALGYSKRVHLMNP
HHHCCCCCCEECCCC
50.3726320211
221PhosphorylationMVPGLTGSKMSSSEE
CCCCCCCCCCCCCHH
21.6820068231
222UbiquitinationVPGLTGSKMSSSEEE
CCCCCCCCCCCCHHH
44.11-
224PhosphorylationGLTGSKMSSSEEESK
CCCCCCCCCCHHHHH
34.1529496963
225PhosphorylationLTGSKMSSSEEESKI
CCCCCCCCCHHHHHH
37.9730108239
226PhosphorylationTGSKMSSSEEESKID
CCCCCCCCHHHHHHC
41.5423186163
230PhosphorylationMSSSEEESKIDLLDR
CCCCHHHHHHCHHCC
37.89-
231UbiquitinationSSSEEESKIDLLDRK
CCCHHHHHHCHHCCH
43.44-
231AcetylationSSSEEESKIDLLDRK
CCCHHHHHHCHHCCH
43.4423236377
237MethylationSKIDLLDRKEDVKKK
HHHCHHCCHHHHHHH
44.21115920161
238SuccinylationKIDLLDRKEDVKKKL
HHCHHCCHHHHHHHH
58.9123954790
244AcetylationRKEDVKKKLKKAFCE
CHHHHHHHHHHHHCC
60.88125905199
247UbiquitinationDVKKKLKKAFCEPGN
HHHHHHHHHHCCCCC
58.07-
247AcetylationDVKKKLKKAFCEPGN
HHHHHHHHHHCCCCC
58.0726051181
250S-nitrosocysteineKKLKKAFCEPGNVEN
HHHHHHHCCCCCCCC
8.03-
250S-nitrosylationKKLKKAFCEPGNVEN
HHHHHHHCCCCCCCC
8.0319483679
262PhosphorylationVENNGVLSFIKHVLF
CCCCCHHHHHHHHHH
23.6324719451
272AcetylationKHVLFPLKSEFVILR
HHHHHCCCCCEEEEE
48.4519608861
272UbiquitinationKHVLFPLKSEFVILR
HHHHHCCCCCEEEEE
48.45-
279MethylationKSEFVILRDEKWGGN
CCCEEEEECCCCCCC
38.63115920165
282UbiquitinationFVILRDEKWGGNKTY
EEEEECCCCCCCCEE
56.26-
2822-HydroxyisobutyrylationFVILRDEKWGGNKTY
EEEEECCCCCCCCEE
56.26-
287UbiquitinationDEKWGGNKTYTAYVD
CCCCCCCCEEEEEEE
46.30-
292PhosphorylationGNKTYTAYVDLEKDF
CCCEEEEEEECCCCE
6.16-
297UbiquitinationTAYVDLEKDFAAEVV
EEEEECCCCEECEEE
66.50-
310AcetylationVVHPGDLKNSVEVAL
EECCCCCCHHHHHHH
52.4923954790
310UbiquitinationVVHPGDLKNSVEVAL
EECCCCCCHHHHHHH
52.49-
319AcetylationSVEVALNKLLDPIRE
HHHHHHHHHHHHHHH
51.8023236377
327UbiquitinationLLDPIREKFNTPALK
HHHHHHHHCCCHHHH
33.78-
327AcetylationLLDPIREKFNTPALK
HHHHHHHHCCCHHHH
33.7827452117
330PhosphorylationPIREKFNTPALKKLA
HHHHHCCCHHHHHHH
17.0529083192
334UbiquitinationKFNTPALKKLASAAY
HCCCHHHHHHHHHCC
48.09-
334MalonylationKFNTPALKKLASAAY
HCCCHHHHHHHHHCC
48.0926320211
334AcetylationKFNTPALKKLASAAY
HCCCHHHHHHHHHCC
48.0925953088
335UbiquitinationFNTPALKKLASAAYP
CCCHHHHHHHHHCCC
50.57-
335MalonylationFNTPALKKLASAAYP
CCCHHHHHHHHHCCC
50.5726320211
338PhosphorylationPALKKLASAAYPDPS
HHHHHHHHHCCCCHH
24.7025159151
356UbiquitinationPMAKGPAKNSEPEEV
CCCCCCCCCCCCCCC
65.23-
356MalonylationPMAKGPAKNSEPEEV
CCCCCCCCCCCCCCC
65.2326320211
358PhosphorylationAKGPAKNSEPEEVIP
CCCCCCCCCCCCCCC
54.5521815630
374UbiquitinationRLDIRVGKIITVEKH
CCEEEECEEEEEEEC
28.25-
374AcetylationRLDIRVGKIITVEKH
CCEEEECEEEEEEEC
28.2525953088
377PhosphorylationIRVGKIITVEKHPDA
EEECEEEEEEECCCC
26.53-
380UbiquitinationGKIITVEKHPDADSL
CEEEEEEECCCCCCE
56.98-
380AcetylationGKIITVEKHPDADSL
CEEEEEEECCCCCCE
56.9826822725
386PhosphorylationEKHPDADSLYVEKID
EECCCCCCEEEEEEC
24.2628450419
388PhosphorylationHPDADSLYVEKIDVG
CCCCCCEEEEEECCC
15.5428796482
391UbiquitinationADSLYVEKIDVGEAE
CCCEEEEEECCCCCC
33.8821906983
400MethylationDVGEAEPRTVVSGLV
CCCCCCCCEEEEEEE
31.49115920169
412UbiquitinationGLVQFVPKEELQDRL
EEEEECCHHHHHHCE
59.5221906983
412AcetylationGLVQFVPKEELQDRL
EEEEECCHHHHHHCE
59.5226051181
418MethylationPKEELQDRLVVVLCN
CHHHHHHCEEEEEEC
19.20115920173
427UbiquitinationVVVLCNLKPQKMRGV
EEEEECCCCHHCCCC
31.26-
427MalonylationVVVLCNLKPQKMRGV
EEEEECCCCHHCCCC
31.2626320211
427AcetylationVVVLCNLKPQKMRGV
EEEEECCCCHHCCCC
31.2625953088
430UbiquitinationLCNLKPQKMRGVESQ
EECCCCHHCCCCCCC
38.81-
430AcetylationLCNLKPQKMRGVESQ
EECCCCHHCCCCCCC
38.8126051181
432MethylationNLKPQKMRGVESQGM
CCCCHHCCCCCCCCC
53.71115920177
436PhosphorylationQKMRGVESQGMLLCA
HHCCCCCCCCCEEHH
29.63-
439SulfoxidationRGVESQGMLLCASIE
CCCCCCCCEEHHHHC
1.6821406390
442GlutathionylationESQGMLLCASIEGIN
CCCCCEEHHHHCCCC
2.1622555962
444PhosphorylationQGMLLCASIEGINRQ
CCCEEHHHHCCCCCC
21.8528348404
470UbiquitinationPGEHVFVKGYEKGQP
CCCEEEEECCCCCCC
44.2921906983
470AcetylationPGEHVFVKGYEKGQP
CCCEEEEECCCCCCC
44.2923236377
474AcetylationVFVKGYEKGQPDEEL
EEEECCCCCCCCCCC
55.1319608861
474UbiquitinationVFVKGYEKGQPDEEL
EEEECCCCCCCCCCC
55.1319608861
474MalonylationVFVKGYEKGQPDEEL
EEEECCCCCCCCCCC
55.1326320211
482AcetylationGQPDEELKPKKKVFE
CCCCCCCCCCHHHHH
59.0619608861
482UbiquitinationGQPDEELKPKKKVFE
CCCCCCCCCCHHHHH
59.06-
482MalonylationGQPDEELKPKKKVFE
CCCCCCCCCCHHHHH
59.0626320211
4842-HydroxyisobutyrylationPDEELKPKKKVFEKL
CCCCCCCCHHHHHHH
64.73-
490AcetylationPKKKVFEKLQADFKI
CCHHHHHHHHHHHCC
34.1419608861
490UbiquitinationPKKKVFEKLQADFKI
CCHHHHHHHHHHHCC
34.1419608861
4902-HydroxyisobutyrylationPKKKVFEKLQADFKI
CCHHHHHHHHHHHCC
34.14-
490MalonylationPKKKVFEKLQADFKI
CCHHHHHHHHHHHCC
34.1426320211
501S-nitrosocysteineDFKISEECIAQWKQT
HHCCCHHHHHHHHHC
2.47-
501GlutathionylationDFKISEECIAQWKQT
HHCCCHHHHHHHHHC
2.4722555962
501S-nitrosylationDFKISEECIAQWKQT
HHCCCHHHHHHHHHC
2.4719483679
506UbiquitinationEECIAQWKQTNFMTK
HHHHHHHHHCCHHHH
34.85-
506AcetylationEECIAQWKQTNFMTK
HHHHHHHHHCCHHHH
34.8526051181
513UbiquitinationKQTNFMTKLGSISCK
HHCCHHHHHCCEECC
38.7821906983
513AcetylationKQTNFMTKLGSISCK
HHCCHHHHHCCEECC
38.7825953088
516PhosphorylationNFMTKLGSISCKSLK
CHHHHHCCEECCCCC
23.0523312004
518PhosphorylationMTKLGSISCKSLKGG
HHHHCCEECCCCCCC
19.7223312004
520UbiquitinationKLGSISCKSLKGGNI
HHCCEECCCCCCCCC
52.62-
520AcetylationKLGSISCKSLKGGNI
HHCCEECCCCCCCCC
52.6225953088
521PhosphorylationLGSISCKSLKGGNIS
HCCEECCCCCCCCCC
39.37-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of SYYC_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SYYC_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SYYC_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
NRDC_HUMANNRD1physical
22863883
SARNP_HUMANSARNPphysical
22863883
DDB1_HUMANDDB1physical
26344197
EIF1B_HUMANEIF1Bphysical
26344197
G3BP2_HUMANG3BP2physical
26344197
HNRH2_HUMANHNRNPH2physical
26344197
NAA10_HUMANNAA10physical
26344197
NAA15_HUMANNAA15physical
26344197
PLPHP_HUMANPROSCphysical
26344197
TATD1_HUMANTATDN1physical
26344197
SYYM_HUMANYARS2physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
608323Charcot-Marie-Tooth disease, dominant, intermediate type, C (CMTDIC)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
DB00135L-Tyrosine
Regulatory Network of SYYC_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-197; LYS-206; LYS-272;LYS-474; LYS-482 AND LYS-490, AND MASS SPECTROMETRY.

TOP